340 related articles for article (PubMed ID: 18851715)
1. Cytoprotective effects of IAPs revealed by a small molecule antagonist.
Galbán S; Hwang C; Rumble JM; Oetjen KA; Wright CW; Boudreault A; Durkin J; Gillard JW; Jaquith JB; Morris SJ; Duckett CS
Biochem J; 2009 Feb; 417(3):765-71. PubMed ID: 18851715
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
[TBL] [Abstract][Full Text] [Related]
3. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
Moon JH; Shin JS; Hong SW; Jung SA; Hwang IY; Kim JH; Choi EK; Ha SH; Kim JS; Kim KM; Hong DW; Kim D; Kim YS; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Hattersley M; Jin DH; Kim TW
Oncotarget; 2015 Sep; 6(29):26895-908. PubMed ID: 26314849
[TBL] [Abstract][Full Text] [Related]
4. The non-peptidomimetic IAP antagonist ASTX660 sensitizes colorectal cancer cells for extrinsic apoptosis.
Knoll G; Ehrenschwender M
FEBS Open Bio; 2021 Mar; 11(3):714-723. PubMed ID: 33484626
[TBL] [Abstract][Full Text] [Related]
5. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.
Li L; Thomas RM; Suzuki H; De Brabander JK; Wang X; Harran PG
Science; 2004 Sep; 305(5689):1471-4. PubMed ID: 15353805
[TBL] [Abstract][Full Text] [Related]
6. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.
Ndubaku C; Varfolomeev E; Wang L; Zobel K; Lau K; Elliott LO; Maurer B; Fedorova AV; Dynek JN; Koehler M; Hymowitz SG; Tsui V; Deshayes K; Fairbrother WJ; Flygare JA; Vucic D
ACS Chem Biol; 2009 Jul; 4(7):557-66. PubMed ID: 19492850
[TBL] [Abstract][Full Text] [Related]
8. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
9. IAP family of cell death and signaling regulators.
Silke J; Vucic D
Methods Enzymol; 2014; 545():35-65. PubMed ID: 25065885
[TBL] [Abstract][Full Text] [Related]
10. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R
J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
[TBL] [Abstract][Full Text] [Related]
11. Concomitant activation of caspase-9 and down-regulation of IAP proteins as a mechanism of apoptotic death in HepG2, T47D and HCT-116 cells upon exposure to a derivative from 4-aryl-4H-chromenes family.
Mahdavi M; Davoodi J; Zali MR; Foroumadi A
Biomed Pharmacother; 2011 Jun; 65(3):175-82. PubMed ID: 21565459
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-dependent expression of IAP participates in the protection against TNF-mediated cytotoxicity in MCF7 cells.
Mitre-Aguilar IB; Barrios-Garcia T; Ruiz-Lopez VM; Cabrera-Quintero AJ; Mejia-Dominguez NR; Ventura-Gallegos JL; Moreno-Mitre D; Aranda-Gutierrez A; Mejia-Rangel J; Escalona-Guzman AR; Chavarri-Guerra Y; Leon-Del-Rio A; Zentella-Dehesa A
BMC Cancer; 2019 Apr; 19(1):356. PubMed ID: 30987626
[TBL] [Abstract][Full Text] [Related]
13. Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER).
Ohoka N; Ujikawa O; Shimokawa K; Sameshima T; Shibata N; Hattori T; Nara H; Cho N; Naito M
Chem Pharm Bull (Tokyo); 2019 Mar; 67(3):203-209. PubMed ID: 30369550
[TBL] [Abstract][Full Text] [Related]
14. Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain.
Donnell AF; Michoud C; Rupert KC; Han X; Aguilar D; Frank KB; Fretland AJ; Gao L; Goggin B; Hogg JH; Hong K; Janson CA; Kester RF; Kong N; Le K; Li S; Liang W; Lombardo LJ; Lou Y; Lukacs CM; Mischke S; Moliterni JA; Polonskaia A; Schutt AD; Solis DS; Specian A; Taylor RT; Weisel M; Remiszewski SW
J Med Chem; 2013 Oct; 56(20):7772-87. PubMed ID: 24083782
[TBL] [Abstract][Full Text] [Related]
15. WX20120108, a novel IAP antagonist, induces tumor cell autophagy via activating ROS-FOXO pathway.
Ding R; Wang X; Chen W; Li Z; Wei AL; Wang QB; Nie AH; Wang LL
Acta Pharmacol Sin; 2019 Nov; 40(11):1466-1479. PubMed ID: 31316176
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule IAP antagonists sensitize cancer cells to TRAIL-induced apoptosis: roles of XIAP and cIAPs.
Finlay D; Vamos M; González-López M; Ardecky RJ; Ganji SR; Yuan H; Su Y; Cooley TR; Hauser CT; Welsh K; Reed JC; Cosford ND; Vuori K
Mol Cancer Ther; 2014 Jan; 13(1):5-15. PubMed ID: 24194568
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of apoptotic proteins: new targets for anticancer therapy.
Saleem M; Qadir MI; Perveen N; Ahmad B; Saleem U; Irshad T; Ahmad B
Chem Biol Drug Des; 2013 Sep; 82(3):243-51. PubMed ID: 23790005
[TBL] [Abstract][Full Text] [Related]
18. Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer.
Foster FM; Owens TW; Tanianis-Hughes J; Clarke RB; Brennan K; Bundred NJ; Streuli CH
Breast Cancer Res; 2009; 11(3):R41. PubMed ID: 19563669
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists.
Beug ST; Conrad DP; Alain T; Korneluk RG; Lacasse EC
Int J Dev Biol; 2015; 59(1-3):141-7. PubMed ID: 26374535
[TBL] [Abstract][Full Text] [Related]
20. The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy.
de Almagro MC; Vucic D
Exp Oncol; 2012 Oct; 34(3):200-11. PubMed ID: 23070005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
